Science Explorer Interactive view Map
Company · Durham · United States

Viamet Pharmaceuticals (United States)

viamet.comROR OpenAlex
Research works
22
▼ 73% vs 2013–17
Citations
1.4k
61.3 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Viamet Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Viamet Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antifungal Therapy, Epidemiology, Immunocompromised Patients, Candidiasis, Invasive Fungal Infections, Hormone Therapy, Virulence Factors and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Antifungal Therapy8▲ 348×3 topics
  2. Epidemiology7▲ 8.1×13 topics
  3. Immunocompromised Patients5▲ 328×2 topics
  4. Candidiasis5▲ 445×1 topic
  5. Invasive Fungal Infections5▲ 555×1 topic
  6. Hormone Therapy3▲ 111×2 topics
  7. Clinical Trials2▲ 15×2 topics
  8. Virulence Factors2▲ 51×3 topics
  9. Genetic Mutations2▲ 18×2 topics
  10. Immunotherapy2▲ 14×2 topics
  11. Androgen Receptor2▲ 96×1 topic
  12. Cryptococcal Disease2▲ 277×1 topic
  13. Histoplasmosis2▲ 277×1 topic
  14. Prostate Cancer2▲ 59×1 topic
  15. PET Imaging2▲ 36×2 topics
  16. Tumor Microenvironment2▲ 20×2 topics
  17. Diagnosis1▲ 6.2×5 topics
  18. Transcriptional Regulation1▲ 21×2 topics
  19. Breast Cancer1▲ 18×2 topics
  20. Cancer Therapy1▲ 8.2×2 topics
  21. Estrogen1▲ 67×1 topic
  22. Receptor1▲ 70×1 topic
  23. Antiretroviral Therapy1▲ 20×3 topics

Which research topics does Viamet Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Pancreatic function and diabetes, Diabetes Management and Research and Diabetes, Cardiovascular Risks, and Lipoproteins.

  1. 1 Pancreatic function and diabetes Surgery 0 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.9%not open46.1%

World: 28% of research is openly available.

with international co-authors22.4%domestic only77.6%

World: 19% is written across borders.

How has Viamet Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 73% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.